These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 24968257)
1. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257 [TBL] [Abstract][Full Text] [Related]
2. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707 [TBL] [Abstract][Full Text] [Related]
3. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402 [TBL] [Abstract][Full Text] [Related]
4. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948 [TBL] [Abstract][Full Text] [Related]
5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591 [TBL] [Abstract][Full Text] [Related]
6. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737 [TBL] [Abstract][Full Text] [Related]
7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156 [TBL] [Abstract][Full Text] [Related]
8. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009219. PubMed ID: 27669661 [TBL] [Abstract][Full Text] [Related]
9. Platinum-induced hearing loss after treatment for childhood cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906 [TBL] [Abstract][Full Text] [Related]
10. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. Peinemann F; Tushabe DA; van Dalen EC; Berthold F Cochrane Database Syst Rev; 2015 May; 2015(5):CD010774. PubMed ID: 25989478 [TBL] [Abstract][Full Text] [Related]
11. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Yalçin B; Kremer LC; Caron HN; van Dalen EC Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444 [TBL] [Abstract][Full Text] [Related]
13. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801 [TBL] [Abstract][Full Text] [Related]
14. Platinum-containing regimens for metastatic breast cancer. Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430 [TBL] [Abstract][Full Text] [Related]
15. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for children with medulloblastoma. Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Yalçin B; Kremer LC; van Dalen EC Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598 [TBL] [Abstract][Full Text] [Related]
18. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma. Kraal KC; van Dalen EC; Tytgat GA; Van Eck-Smit BL Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010349. PubMed ID: 28429876 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743 [TBL] [Abstract][Full Text] [Related]
20. Platinum-containing regimens for triple-negative metastatic breast cancer. Egger SJ; Chan MMK; Luo Q; Wilcken N Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013750. PubMed ID: 33084020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]